{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:44:48Z","timestamp":1788587088844,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.drugalcdep.2019.107574","type":"journal-article","created":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T09:29:21Z","timestamp":1569144561000},"page":"107574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Patterns of non-prescribed buprenorphine and other opioid use among individuals with opioid use disorder: A latent class analysis"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6507-3866","authenticated-orcid":false,"given":"Raminta","family":"Daniulaityte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramzi W.","family":"Nahhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Silverstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Zaragoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4244-0173","authenticated-orcid":false,"given":"Robert G.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.107574_bib0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neubiorev.2015.06.012","article-title":"How fast and how often: the pharmacokinetics of drug use are decisive in addiction","volume":"56","author":"Allain","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jsat.2016.08.002","article-title":"Non-prescribed buprenorphine in New York City: motivations for use, practices of diversion, and experiences of stigma","volume":"70","author":"Allen","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jsat.2010.05.004","article-title":"Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national surveys of physicians","volume":"39","author":"Arfken","year":"2010","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0020","series-title":"Auxiliary Variables in Mixture Modeling: A 3-Step Approach Using Mplus.Mplus Web Notes No. 15. Version 5. October 4","author":"Asparouhov","year":"2012"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ADM.0b013e3182034e31","article-title":"Illicit use of Buprenorphine\/Naloxone among injecting and noninjecting opioid users","volume":"5","author":"Bazazi","year":"2011","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13722-017-0072-2","article-title":"Public sector low threshold office-based buprenorphine treatment: outcomes at year 7","volume":"12","author":"Bhatraju","year":"2017","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0035","series-title":"Pathways from Heroin Addiction: Recovery without Treatment","author":"Biernacki","year":"1986"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.drugalcdep.2015.12.026","article-title":"Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: a natural history study","volume":"160","author":"Carlson","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugalcdep.2005.01.011","article-title":"Drug use practices among MDMA\/Ecstasy users in Ohio: a latent class analysis","volume":"79","author":"Carlson","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0050","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/ADM.0000000000000436","article-title":"The more things change: Buprenorphine\/Naloxone diversion continues while treatment remains inaccessible","volume":"12","author":"Carroll","year":"2018","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1526-4637.2006.00259.x","article-title":"The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS)","volume":"8","author":"Cicero","year":"2007","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2018.09.007","article-title":"Understanding the use of diverted buprenorphine","volume":"193","author":"Cicero","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drugalcdep.2014.06.005","article-title":"Factors contributing to the rise of buprenorphine misuse: 2008\u20132013","volume":"142","author":"Cicero","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0070","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0277-9536(99)00390-1","article-title":"Constructions of masculinity and their influence on men\u2019s well-being: a theory of gender and health","volume":"50","author":"Courtenay","year":"2000","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/ADM.0b013e31829727b2","article-title":"Prior buprenorphine experience is associated with office-based buprenorphine treatment outcomes","volume":"7","author":"Cunningham","year":"2013","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0080","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s11606-017-3993-2","article-title":"Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention","volume":"32","author":"D\u2019Onofrio","year":"2017","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drugpo.2019.05.020","article-title":"Street fentanyl use: experiences, preferences, and concordance between self-reports and urine toxicology","volume":"71","author":"Daniulaityte","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.drugalcdep.2011.09.029","article-title":"Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids","volume":"122","author":"Daniulaityte","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0095","doi-asserted-by":"crossref","first-page":"904","DOI":"10.15585\/mmwr.mm6634a3","article-title":"Overdose deaths related to fentanyl and its analogs - Ohio, january-february 2017","volume":"66","author":"Daniulaityte","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0100","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.drugalcdep.2019.01.045","article-title":"Trends in fentanyl and fentanyl analogue-related overdose deaths \u2013 Montgomery County, Ohio, 2015\u20132017","volume":"198","author":"Daniulaityte","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","article-title":"Self-report among injecting drug users: a review","volume":"51","author":"Darke","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0110","series-title":"National Forensic Laboratory Information System (NFLIS) 2017 Annual Report","author":"DEA","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0115","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1360-0443.2011.03473.x","article-title":"Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials","volume":"107","author":"Donovan","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1370\/afm.2098","article-title":"Mortality associated with time in and out of buprenorphine treatment in french office-based general practice: a 7-year cohort study","volume":"15","author":"Dupouy","year":"2017","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.08.029","article-title":"Twin epidemics: the surging rise of methamphetamine use in chronic opioid users","volume":"193","author":"Ellis","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0130","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00127-008-0371-8","article-title":"Individual characteristics of the literally homeless, marginally housed, and impoverished in a US substance abuse treatment-seeking sample","volume":"43","author":"Eyrich-Garg","year":"2008","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jsat.2005.02.008","article-title":"Nonmedical drug use among stimulant-using adults in small towns in rural Ohio","volume":"28","author":"Falck","year":"2005","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0140","first-page":"e2823","article-title":"Maintenance Drugs to Treat Opioid Dependence","volume":"344","author":"Farrell","year":"2012","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jsat.2004.06.005","article-title":"Consensus statement on office-based treatment of opioid dependence using buprenorphine","volume":"27","author":"Fiellin","year":"2004","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2004.03.012","article-title":"Selection of a substance use disorder diagnostic instrument by the national drug abuse treatment clinical trials network","volume":"27","author":"Forman","year":"2004","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jsat.2014.07.015","article-title":"Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants","volume":"48","author":"Fox","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0160","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1016\/j.addbeh.2013.08.008","article-title":"Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland","volume":"38","author":"Genberg","year":"2013","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0165","series-title":"Buprenorphine for the Management of Opioid Withdrawal. Cochrane Database of Systematic Reviews (Online) (3)","author":"Gowing","year":"2009"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0170","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.drugpo.2012.10.003","article-title":"Methadone diversion as a protective strategy: the harm reduction potential of\u2019 generous constraints\u2019","volume":"24","author":"Harris","year":"2013","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0175","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (Redcap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0180","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/biomet\/75.2.383","article-title":"A comparison of two modified bonferroni procedures","volume":"75","author":"Hommel","year":"1988","journal-title":"Biometrika"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2017.04.005","article-title":"Why aren\u2019t physicians prescribing more buprenorphine?","volume":"78","author":"Huhn","year":"2017","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0190","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment","volume":"105","author":"Jones","year":"2015","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0195","series-title":"Promoting Self-Change From Addictive Behaviors","author":"Klingemann","year":"2007"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2019.05.002","article-title":"Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: addressing a critical care gap","volume":"103","author":"Krawczyk","year":"2019","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsat.2014.02.003","article-title":"Abuse and diversion of buprenorphine sublingual tablets and film","volume":"47","author":"Lavonas","year":"2014","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0210","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2018.01.015","article-title":"Perceptions and practices addressing diversion among us buprenorphine prescribers","volume":"186","author":"Lin","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0215","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.drugalcdep.2012.05.025","article-title":"Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine","volume":"126","author":"Lofwall","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0220","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000045","article-title":"A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world","volume":"8","author":"Lofwall","year":"2014","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0225","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1300\/J069v26n01_08","article-title":"Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program","volume":"26","author":"Maremmani","year":"2007","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0230","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.drugalcdep.2015.03.020","article-title":"Racial\/ethnic differences in trends in heroin use and heroin-related risk behaviors among nonmedical prescription opioid users","volume":"151","author":"Martins","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0235","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/10550490903077820","article-title":"Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland","volume":"18","author":"Mitchell","year":"2009","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2015.04.010","article-title":"Prior experience with non-prescribed buprenorphine: role in treatment entry and retention","volume":"57","author":"Monico","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0245","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/10550880903014767","article-title":"Diversion of Buprenorphine\/Naloxone coformulated tablets in a region with high prescribing prevalence","volume":"28","author":"Monte","year":"2009","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0250","series-title":"Mplus User\u2019s Guide","author":"Muth\u00e9n","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0255","series-title":"2017 Ohio Drug Overdose Data: General Finindgs ODH, Columbus, OH.","author":"Ohio Department of Health","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0260","series-title":"Surveillance of Drug Abuse Trends in the State of Ohio, June 2016-January 2017","author":"Ohio Substance Abuse Monitoring Network","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0265","series-title":"Accidental Overdose Death Totals","author":"Public Health Dayton & Montgomery County","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0270","series-title":"Diagnostic Interview Schedule for DSM-IV","author":"Robins","year":"2002"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0275","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1037\/a0030992","article-title":"Reliability of the timeline followback for cocaine, cannabis, and cigarette use","volume":"28","author":"Robinson","year":"2014","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0280","series-title":"Behavioral Health Barometer: United States, Volume 4: Indicators As Measured Through the 2014 National Survey on Drug Use and Health and National Survey of Substance Abuse Treatment Services. Substance Abuse and Mental Health Services Administration","author":"SAMHSA","year":"2015"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0285","series-title":"Behavioral Health Barometer: United States, Volume 4: Indicators As Measured Through the 2015 National Survey on Drug Use and Health and National Survey of Substance Abuse Treatment Services.. Substance Abuse and Mental Health Services Administration","author":"SAMHSA","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0290","series-title":"Sas Version 9.4","author":"SAS Institute Inc","year":"2012"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0295","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsat.2010.03.014","article-title":"Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers","volume":"39","author":"Schuman-Olivier","year":"2010","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0300","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/02791072.1994.10472440","article-title":"Injection drug users in the Midwest: an epidemiologic comparison of drug use patterns in four Ohio cities","volume":"26","author":"Siegal","year":"1994","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0305","series-title":"Measuring Alcohol Consumption: Psychosocial and Biological Methods","first-page":"41","article-title":"Timeline follow-back: a technique for assessing sel-freported alcohol consumption","author":"Sobell","year":"1992"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0310","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/00952990.2018.1461876","article-title":"Characteristics and experiences of buprenorphine-naloxone use among polysubstance users","volume":"44","author":"Walker","year":"2018","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0315","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/10550887.2011.642757","article-title":"The emerging buprenorphine epidemic in the United States","volume":"31","author":"Wish","year":"2012","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0320","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","article-title":"Treatment utilization among persons with opioid use disorder in the United States","volume":"169","author":"Wu","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107574_bib0325","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and Buprenorphine\/naloxone diversion, misuse, and illicit use: an international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Curr. Drug Abuse Rev."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619303515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619303515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:02:30Z","timestamp":1759827750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619303515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":65,"alternative-id":["S0376871619303515"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107574","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of non-prescribed buprenorphine and other opioid use among individuals with opioid use disorder: A latent class analysis","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107574"}}